SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wisee who wrote (640)5/10/1998 11:07:00 PM
From: SOROS  Read Replies (1) of 1185
 
That is what I would like to know. What other small biotech companies have gotten this kind of a deal from a company as large as LaRoche and what were the outcomes? Surely, everyone has to agree that a lot of the uncertainty an investor has with biotechs has been alleviated by Hoffmann-LaRoche.

Also, why is this deal not as good or better than the Forbes Medi-Tech, and why should Nortran's share price not equal theirs? Answers anyone?

I remain,

SOROS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News